All the Active Ingredient Drugs
Carbonic Anhydrase Inhibitor, Nonselective β-Blocker. Brinzolamide 10 mg/ml, Timolol Maleate 5 mg/ml. BOTTLE: 5 ml. 1 dr ×2/d in conjunctival sac of the affected eye(s). See lit.
Decrease of intra-ocular pressure (IOP) in adult pts. with open-ang. glauc. or ocular hypertens. for whom monother. provides insuffic. IOP reduct.
C/I: Hypersens. Hypersens. to other β-block. Hypersens. to sulphonamides.
Reactive airway dis. include. bronch. asthma/history of bronch. asthma, or severe COPD. Sinus bradycardia, sick sinus synd., sino-atrial block, 2nd/3rd degree AV block not control. with pace-maker. Overt CF, cardiogenic shock. Severe allergic rhinitis. Hyperchloraemic acidosis. Sev. renal impair.
Carbonic Anhydrase Inhibitor, α2 Agonist. Brinzolamide 10 mg/ml, Brimonidine Tartrate 2 mg/ml. BOTTLE: 5 ml. 1 dr×2/d in the affected eye(s). See lit.
Decrease of elevated intraoc. pressure (IOP) in adult pts. with open-ang. glauc. or ocular hypertens. for whom monotherapy provides insuffic. IOP reduct.
C/I: Hypersens. Hypersens. to sulphonamides. Pts. receiving MAO inhib.
Pts on antidepressant. which affect noradrenergic transmission (e.g. TCA's & mianserin). Pts. with severe renal impair. Pts. with hyperchloraemic acidosis.
Neonates & infants under the age of 2 yrs.